Document is current
Any future updates will be listed below
-
Authors
Newman, Alexandra Bili
Basen-Engquist, Karen
Gilchrist, Susan C.
Nohria, Anju
Kerrigan, Dennis
Keteyian, Steven J.
Schmitz, Kathryn H.
Ligibel, Jennifer A.
- License Information
-
More Information
Article History
Accepted: 11 April 2022
First Online: 10 September 2022
Declarations
:
: A Nohria has received research support from Amgen, Inc. and is a consultant for AstraZeneca, Bantam Pharmaceuticals, Boehringer Ingelheim, and Takeda Oncology. J Ligibel has received in-kind product support (to Dana-Farber) from Fitbit and Nestle Health Science in support of the Breast Cancer Weight Loss Study. S Gilchrist reports no conflicts of interest. Of note, after manuscript completion, Dr. Gilchrist started full-time employment with LabCorp. Her employment at LabCorp did not create any new conflicts related to the manuscript. The authors Newman, Basen-Engquist, Kerrigan, Keteyian, and Schmitz report no financial conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
